FDA Drug Application (021859) for HYLENEX RECOMBINANT by HALOZYME THERAP

Back to FDA Applications sponsored by HALOZYME THERAP

Application Number021859
Product Number001
FormINJECTABLE;INJECTION
Dosage150 UNITS/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYLENEX RECOMBINANT
Active IngredientHYALURONIDASE RECOMBINANT HUMAN



Back to FDA Applications sponsored by HALOZYME THERAP